Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.46
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Leflunomide in Disease Modifying Treatment of Rheumatoid Arthritis in Elderly Patients

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2008English

Suppressed Wound Healing in a Patient With Rheumatoid Arthritis Taking Leflunomide (Arava)

Permanente journal,The
Medicine
2011English

Elevated Liver Enzyme Tests Among Patients With Rheumatoid Arthritis or Psoriatic Arthritis Treated With Methotrexate and/or Leflunomide

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2009English

Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Efficiency and Safety of Leflunomide in Rheumatoid Arthritis: Results of a Russian Observational Multicenter of Trial

Modern Rheumatology Journal
2015English

Microchimerism in the Rheumatoid Nodules of Patients With Rheumatoid Arthritis

Arthritis & Rheumatism
2012English

Enteroparasitoses in Patients With Rheumatoid Arthritis

Advances in Infectious Diseases
2017English

Microalbuminuria in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1995English

Physiologically Based Pharmacokinetic Modeling of Chloroethane Disposition in Mice, Rats, and Women

Toxicological Sciences
Toxicology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy